In recent years, medications like Zepbound and Ozempic have gained significant attention for their roles in weight management and blood sugar control. These drugs are part of a rapidly expanding market, with the global GLP-1 agonist weight loss drugs market valued at $13.84 billion in 2024 and projected to grow at 18.54% from 2025 to 2030.
While they’re often compared, they aren’t the same. Each one works differently, costs a different amount, and affects people in unique ways. In this article, you’ll learn how Zepbound vs. Ozempic stack up when it comes to results, pricing, and what real users have experienced.
Is Zepbound more effective than Ozempic for weight loss?
There are no studies yet directly comparing Zepbound and Ozempic for weight loss. However, a 2024 study compared tirzepatide and semaglutide in their type 2 diabetes formulations (Mounjaro and Ozempic) in real-world settings for weight management. Both Zepbound and Mounjaro contain the same active ingredient, tirzepatide, and are available in the same dosage strengths.
This study may give us an idea of what to expect when comparing Zepbound and Ozempic for weight loss.
The researchers analyzed data from over 41,000 adults with overweight or obesity, with or without type 2 diabetes. None of the participants had previously used these types of medications, and they were followed for up to one year after starting treatment.
The results showed that people taking tirzepatide lost significantly more weight than those taking semaglutide:
| Outcome at 12 Months | Tirzepatide (Zepbound) | Semaglutide (Ozempic) |
|---|---|---|
| % who lost 5% or more of body weight | 82% | 67% |
| % who lost 15% or more of body weight | 42% | 18% |
| Average % body weight lost | 15.3% | 8.3% |
Another real-world study followed 945 adults with overweight or obesity to assess how much weight they lost over 6 months when prescribed tirzepatide or semaglutide.
Here’s what they found:
| Outcome | Tirzepatide (Zepbound) | Semaglutide (Ozempic) |
|---|---|---|
| Average weight loss (kg) | 6.6 kg (14.6 lbs) | 3.1 kg (6.8 lbs) |
| Average % body weight lost | 5.3% | 2.7% |
| % of patients who lost 5% weight or more | 49% | 26% |
| % of patients who lost 10% weight or more | 23% | 9% |
| % of patients who lost 15% weight or more | 10% | 3% |
| % weight loss in patients without type 2 diabetes | 7.0% | 3.4% |
These findings suggest that Zepbound may offer a more effective option for significant weight loss compared to Ozempic.
A Real-World Weight Loss Journey with Zepbound and Ozempic
Disclaimer: This section shares one individual’s personal experience with prescription medications for weight loss. It is not medical advice. Results vary, and these medications may not be right for everyone. Always speak with a qualified healthcare provider before starting any treatment.
A 53-year-old man began his weight loss journey at age 49. When he started treatment in 2020, he weighed around 250 pounds and was dealing with several weight-related concerns, including high blood pressure, sleep apnea, and prediabetes.
My 4 Year Experience with Zepbound/Mounjaro and Ozempic – Down from 250 to 170-175 and Stable for 4 Years-53 Year Old Male
byu/Sdg1871 inZepbound
Under the guidance of a board-certified endocrinologist, he began a combination of Ozempic and Qsymia. Eventually, his weight stabilized between 170 and 175 pounds, which he found more sustainable for his height and build.
According to his account, he noticed significant health improvements during this period:
-
- His blood pressure normalized, and he was able to stop using antihypertensive medications.
- He no longer experienced symptoms of sleep apnea.
- His blood sugar levels improved, dropping below the prediabetic range.
As time passed and Ozempic’s effects began to wane, he transitioned to Mounjaro in late 2022. More recently, he switched to Zepbound due to insurance coverage changes, maintaining the benefits he had gained.
His physical transformation was striking:
-
- His waist shrank from 46 to 33 inches
- His shirt size dropped from 3XL to a medium/large
- His neck size has also reduced
Before trying these medications, he had attempted every imaginable diet and exercise program with no lasting success.
Today, he leads an active life without physical limitations. He no longer experiences joint pain and easily completes full days of skiing. Based on his personal experience, he considers Mounjaro and Zepbound more effective and tolerable than Ozempic, particularly for appetite control.
Are Zepbound side effects the same as Ozempic?
Zepbound and Ozempic share many of the same side effects, but Zepbound tends to cause them more often and may have a few additional ones. In separate placebo-controlled trials, adverse reactions reported in patients receiving Ozempic or Zepbound included:
| Reported side effects during clinical trials | % of patients who experienced the side effect with Ozempic | % of patients who experienced the side effect with Zepbound |
|---|---|---|
| Nausea | 15.8-20.3% | 25-28% |
| Abdominal Pain | 5.7-7.3% | 9-10% |
| Diarrhea | 8.5-8.8% | 19-23% |
| Vomiting | 5-9.2% | 8-13% |
| Dyspepsia | 2.7-3.5% | 9-10% |
| Constipation | 3.1-5% | 11-17% |
| Injection Site Reactions | 0.2% | 6-8% |
| Fatigue | Less than 0.4% | 5-7% |
| Hypersensitivity Reactions | Not specified | 5% |
| Eructation | 1.1-2.7% | 4-5% |
| Hair Loss | Not reported | 4-5% |
| Gastroesophageal Reflux Disease (GERD) | 1.5-1.9% | 4-5% |
| Flatulence | 0.4-1.5% | 3-4% |
| Abdominal Distension | Not reported | 3-4% |
| Dizziness | Less than 0.4% | 4-5% |
| Hypotension | Not reported | 1-2% |
Additionally, a slightly higher percentage of patients discontinued treatment due to gastrointestinal side effects with Zepbound at higher doses. Specifically, 3.3% of patients discontinued at the 10 mg dose and 4.3% at the 15 mg dose. In comparison, 3.1% discontinued Ozempic at the 0.5 mg dose, and 3.8% at the 1 mg dose.
Ozempic and Zepbound may also have potential risks or safety concerns that users need to be aware of, such as:
-
- Pancreatitis
- Diabetic Retinopathy
- Hypoglycemia
- Acute Kidney Injury
- Risk of Thyroid C-Cell Tumors
- Hypersensitivity
- Acute Gallbladder Disease
- Suicidal Behavior and Ideation
- Pulmonary Aspiration During General Anesthesia or Deep Sedation (a serious complication where stomach contents accidentally enter the lungs)
Do Zepbound and Ozempic work differently?
Ozempic works by copying a natural hormone in your body called GLP-1. This hormone helps lower blood sugar after meals by:
-
- Telling your body to release more insulin
- Slowing down how fast food leaves your stomach
- Making you feel less hungry
Because of these effects, Ozempic helps people with type 2 diabetes control their blood sugar and may also help with weight loss.
Zepbound goes a step further. It copies two hormones, GLP-1 and another one called GIP. Like GLP-1, GIP helps your body release insulin and may also improve how your body responds to it.
By using both hormones, Zepbound can:
-
- Lower blood sugar more effectively
- Improve insulin resistance
- Lead to more weight loss compared to medications like Ozempic that work on just one hormone
What are the approved indications of Zepbound and Ozempic?
Ozempic is FDA-approved for the following:
-
- Improve blood sugar control in adults with type 2 diabetes.
-
- Lower the risk of serious heart problems like heart attack and stroke in people with type 2 diabetes who already have heart disease.
-
- Slow down the worsening of kidney function and reduce the risk of kidney failure and cardiovascular death in people with type 2 diabetes and chronic kidney disease.
On the other hand, Zepbound is approved as a weight loss medication, not a diabetes treatment. It’s designed for adults with obesity, or for those who are overweight and also have at least one weight-related health issue such as high blood pressure, type 2 diabetes, or high cholesterol. It must be used together with a reduced-calorie diet and increased physical activity.
Recently, Zepbound has also been approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
How do Ozempic and Zepbound dosing schedules compare?
When starting Ozempic, you’ll typically begin with a 0.25 mg injection once a week for the first four weeks. After that, your dose usually increases to 0.5 mg weekly. If your blood sugar still needs improvement, your doctor may increase the dose to 1 mg, and possibly up to a maximum of 2 mg per week, depending on how you respond.
If you’re starting Zepbound, you’ll begin with a 2.5 mg dose once a week for four weeks to let your body get used to the medication. After that, the dose increases to 5 mg weekly. If you need more weight loss support, your dose may be raised by 2.5 mg every four weeks, up to a maximum of 15 mg per week.
For long-term use, your maintenance dose might be 5 mg, 10 mg, or 15 mg weekly, depending on your results. If you’re using Zepbound to treat obstructive sleep apnea, your maintenance dose will likely be 10 mg or 15 mg once a week.
It’s important to know that the starting doses of Ozempic and Zepbound are designed to help your body adjust before you move on to higher, more effective doses. They may not deliver the full therapeutic effect right away.
Dosage Chart
Here’s a comparison of the dosing schedules for Ozempic and Zepbound:
| Medication | Starting Dose | Titration Dose | Maximum Dose | ||||
| Month 1 | Month 2 | Month 3 | Month 4 | Month 5+ | |||
| Ozempic (semaglutide) | 0.25 mg once weekly | 0.25 mg per week | 0.5 mg per week | 0.5-1.0 mg per week | 1.0-2.0 mg per week | 1.0-2.0 mg per week | 2.0 mg once weekly |
| Zepbound (tirzepatide) | 2.5 mg once weekly | 2.5 mg per week | 5.0 mg per week | 5.0-7.5 mg per week | 7.5-10 mg per week | 10-12.5 mg per week | 15 mg once weekly |
Is Zepbound more expensive than Ozempic?
Yes. In the US, Ozempic costs around $997.58 per package, and Zepbound is priced at about $1,079.77. Without insurance, these prices can seriously strain your budget, making it tough to afford the medications you need.
That’s why many people in the US look for more affordable options, like ordering through Canadian pharmacy partners such as Pharma Giant, which ships directly to the US.
When you order from Pharma Giant, you could save up to 90% on prescription medications, including Ozempic and Zepbound. You’ll also find extra savings when you order larger quantities (up to a 3-month supply), coupons, and if it’s your first time ordering, you can get 10% off your first purchase.
Does Insurance Cover Ozempic and Zepbound?
To determine if your insurance covers Ozempic or Zepbound, consider these steps:
Does Medicare Cover Zepbound or Ozempic?
Medicare coverage, such as Medicare Part D and some Medicare Advantage plans, includes Ozempic for the treatment of type 2 diabetes and to reduce cardiovascular risk in individuals with type 2 diabetes and known heart disease, when deemed medically necessary by a healthcare provider.
However, a federal law enacted in 2003 prohibits Medicare from covering medications used exclusively for weight loss.
Does Medicaid Cover Zepbound or Ozempic?
Medicaid coverage varies by state, with most programs approving primarily for type 2 diabetes management only. Coverage for weight loss is less common, as Medicaid is not required to include weight management drugs.
In the first quarter of 2023, 39 states offered unrestricted access to at least one GLP-1 receptor agonist, like Ozempic, for diabetes. Anti-obesity drug reimbursements under Medicaid are generally limited to liraglutide (Saxenda) and semaglutide (Wegovy).
Consult your state’s Medicaid formulary or contact your healthcare provider to confirm current coverage details.
Summary
Current evidence suggests that Zepbound leads to more weight loss than Ozempic. This is likely due to Zepbound’s dual action on two hormones, while Ozempic only targets one.
However, Zepbound also causes more digestive side effects, and slightly more people stop taking it because of these issues. Ozempic is approved for type 2 diabetes and heart protection, while Zepbound is approved for weight loss and sleep apnea in people with obesity. Insurance coverage is also easier to get for Ozempic, especially through Medicare and Medicaid.
If weight loss is your main goal, Zepbound may be more effective. If you have type 2 diabetes, Ozempic may be a better fit. Cost is high for both, but options like Pharma Giant can help lower the price.
Frequently Asked Questions
Related Articles
Sources
GLP-1 Agonists Weight Loss Drugs Market Size, Share & Trends Analysis By Drugs (Semaglutide (Wegovy), Tirzepatide (Zepbound)), By Route of Administration, By Distribution Channel, By Region, And Segment forecasts, 2025 – 2030. (n.d.). https://www.grandviewresearch.com/industry-analysis/glp-1-agonists-weight-loss-drugs-market-report
Rodriguez, P. J., Cartwright, B. M. G., Gratzl, S., Brar, R., Baker, C., Gluckman, T. J., & Stucky, N. L. (2024). Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Internal Medicine, 184(9), 1056. https://doi.org/10.1001/jamainternmed.2024.2525
Trinh, H., Donovan, A., & McAdam?Marx, C. (2025). Real?world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting. Diabetes Obesity and Metabolism. https://doi.org/10.1111/dom.16343
Mounjaro Cost Information | With or Without Insurance | Mounjaro® (tirzepatide) injection. (n.d.). https://pricinginfo.lilly.com/mounjaro
Ozempic® Pricing. (n.d.). https://www.novopricing.com/ozempic.html
Ozempic® (semaglutide) injection for Type 2 Diabetes. (n.d.). https://www.ozempic.com/
Zepbound® (tirzepatide) Injection for Adults with Obesity or OSA. (n.d.). Zepbound® (Tirzepatide) Injection. https://zepbound.lilly.com/
Liu, B. Y., & Rome, B. N. (2024). State coverage and reimbursement of antiobesity medications in Medicaid. JAMA, 331(14), 1230. https://doi.org/10.1001/jama.2024.3073
